LAMP2 and hypertensive disorder: Serum anti-LAMP-2 antibody levels were remarkably higher in VAS-HTN patients with active stage and inactive stage than in HC (active vs. HC: (139.65 ± 54.02) vs. (55.21 ± 25.09) ng/ml, P < 0.001; inactive vs. HC: (102.47 ± 49.48) vs. (55.21 ± 25.09) ng/ml, P < 0.001) (Figure 3(b)).